Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Palladium Catalyzed Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112694430B reveals a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-one intermediates, offering high efficiency and substrate compatibility for API manufacturing.
Patent CN115353511A details a safe, one-pot synthesis of carbonyl-bridged biheterocycles using in-situ CO generation, offering reliable pharmaceutical intermediate supply.
Patent CN113045489B details a novel Pd-catalyzed aminocarbonylation route for 3-arylquinolin-2(1H)ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel palladium-catalyzed carbonylation patent CN115286628B enables efficient synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing.
This patent reveals a novel Pd-catalyzed route for 2-trifluoromethyl quinazolinone, offering high yields and broad substrate scope, enabling cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115260080B enables efficient one-step synthesis of indole-3-carboxamide with high substrate tolerance, offering scalable production and cost reduction for pharmaceutical intermediates.
This patent introduces a novel palladium-catalyzed carbonylation route for pyrone derivatives using nitroarenes and molybdenum carbonyl, enabling scalable, cost-efficient synthesis with broad substrate tolerance for pharmaceutical intermediates.
This patent reveals a novel carbonylation method for thioester synthesis, eliminating malodorous thiols and enabling scalable, cost-effective production for pharmaceutical intermediates.
This patent reveals a streamlined Pd-catalyzed carbonylation for 3-benzylidene-2,3-dihydroquinolone, offering enhanced scalability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN117164506B enables scalable, high-yield synthesis of indeno[1,2-b]indole-10(5H)-one with simplified purification, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112538054B details a novel Pd-catalyzed route for 1,2,4-triazole-3-one compounds, offering high efficiency and broad substrate scope for pharmaceutical manufacturing.
Patent CN112239456B enables efficient synthesis of high-purity pharmaceutical intermediates through palladium-catalyzed carbonylation with simplified process and enhanced supply chain reliability.
Patent CN114751883B introduces a novel carbonylation method for benzofuran-3-carboxamide synthesis, enhancing purity and reducing costs in pharmaceutical intermediate manufacturing through simplified process design and improved scalability.
Patent CN119823040A enables efficient one-step production of high-purity dihydroisoquinolinone derivatives through palladium catalysis with TFBen CO source.
This patent reveals a novel one-step palladium-catalyzed carbonylation method for indolo[2,1a]isoquinoline synthesis with enhanced substrate tolerance and simplified manufacturing processes enabling reliable pharmaceutical intermediate supply chains.
Novel palladium-catalyzed methodology enables efficient production of high-purity quinazolinone intermediates with enhanced scalability and cost reduction for pharmaceutical manufacturing.
Patent-CN-7 introduces an efficient one-step palladium-catalyzed method for indolo[2,1a]isoquinoline synthesis offering significant cost reduction and scalable production capabilities.
Patent CN115286556B enables high-purity indolinone ester production using green solvents and catalysts, reducing lead time while enhancing supply chain reliability for pharma intermediates.
Patent CN115246786B enables efficient synthesis of indole and benzoxazine intermediates through palladium catalysis with simplified operations and scalable production for high-purity pharmaceutical applications.